about
Aerobic Exercise as a Tool to Improve Hippocampal Plasticity and Function in Humans: Practical Implications for Mental Health TreatmentSelf-Face Recognition in Schizophrenia: An Eye-Tracking StudyWorking memory and processing speed training in schizophrenia: study protocol for a randomized controlled trial.Luria revisited: cognitive research in schizophrenia, past implications and future challengesThe Psychosis Recent Onset GRoningen Survey (PROGR-S): defining dimensions and improving outcomes in early psychosisTransmembrane protein 108 is required for glutamatergic transmission in dentate gyrusCognitive and neural strategies during control of the anterior cingulate cortex by fMRI neurofeedback in patients with schizophrenia.Current and emergent treatments for symptoms and neurocognitive impairment in schizophrenia.Amphetamine effects on MATRICS Consensus Cognitive Battery performance in healthy adults.Genetics, cognition, and neurobiology of schizotypal personality: a review of the overlap with schizophrenia."To see or not to see: that is the question." The "Protection-Against-Schizophrenia" (PaSZ) model: evidence from congenital blindness and visuo-cognitive aberrations.New Tools for New Research in Psychiatry: A Scalable and Customizable Platform to Empower Data Driven Smartphone Research.Cognitive remediation in schizophrenia-The view from IndiaA Synaptic Function Approach to Investigating Complex Psychiatric Diseases.Antioxidant Treatment with N-acetyl Cysteine Prevents the Development of Cognitive and Social Behavioral Deficits that Result from Perinatal Ketamine TreatmentNeurocognitive Impairments in Unaffected First-degree Relatives of Schizophrenia.Distinct multivariate brain morphological patterns and their added predictive value with cognitive and polygenic risk scores in mental disorders.Adjunctive treatment for cognitive impairment in patients with chronic schizophrenia: a double-blind, placebo-controlled study.Changing facial affect recognition in schizophrenia: effects of training on brain dynamics.Associations between DNA methylation and schizophrenia-related intermediate phenotypes - a gene set enrichment analysisAlterations in cortical network oscillations and parvalbumin neurons in schizophrenia.Pathological Basis for Deficient Excitatory Drive to Cortical Parvalbumin Interneurons in Schizophrenia.Pharmacokinetics and Pharmacodynamics of Lurasidone Hydrochloride, a Second-Generation Antipsychotic: A Systematic Review of the Published Literature.Reliability and validity of the CogState battery Chinese language version in schizophrenia.A genetic deconstruction of neurocognitive traits in schizophrenia and bipolar disorder.Protocol to evaluate the impact of yoga supplementation on cognitive function in schizophrenia: a randomised controlled trialSex differences in TGFB-β signaling with respect to age of onset and cognitive functioning in schizophrenia.Attention/vigilance in schizophrenia: performance results from a large multi-site study of the Consortium on the Genetics of Schizophrenia (COGS).Comprehensive family therapy: an effective approach for cognitive rehabilitation in schizophrenia.Dietary Intake of Sulforaphane-Rich Broccoli Sprout Extracts during Juvenile and Adolescence Can Prevent Phencyclidine-Induced Cognitive Deficits at AdulthoodAberrant Current Source-Density and Lagged Phase Synchronization of Neural Oscillations as Markers for Emerging Psychosis.Increased Blood-Reelin-Levels in First Episode SchizophreniaMetacognition-augmented cognitive remediation training reduces jumping to conclusions and overconfidence but not neurocognitive deficits in psychosisInvestigating the efficacy of an individualized metacognitive therapy program (MCT+) for psychosis: study protocol of a multi-center randomized controlled trialInterleukin-6: the missing element of the neurocognitive deterioration in schizophrenia? The focus on genetic underpinnings, cognitive impairment and clinical manifestation.The Polish Academic Version of the MATRICS Consensus Cognitive Battery (MCCB): Evaluation of Psychometric PropertiesDistinct neural correlates for attention lapses in patients with schizophrenia and healthy participants.Relationship of Cognition to Clinical Response in First-Episode Schizophrenia Spectrum DisordersA quasi-randomized feasibility pilot study of specific treatments to improve emotion recognition and mental-state reasoning impairments in schizophrenia.Changes in event-related potentials in patients with first-episode schizophrenia and their siblings.
P2860
Q26741515-6FA19CB6-8A71-429E-9778-9F1F90384D9DQ27316743-5291F7C5-4927-445D-864C-9BC772058ABBQ27334663-01908039-E38B-4F67-86F9-1C195A0ADEE1Q28087640-E2579743-52A1-48D8-BB2E-3CC84D5B29A0Q28545094-B1608B75-D22E-4DC8-B833-46DE92740363Q28771512-67582464-AD41-467F-A277-12BFFDD101B7Q30376510-2FA55C43-EA18-4251-812A-63BEEA63A2DCQ30382281-BEC24421-EB5F-447C-99F6-1A748239D938Q30439296-F6BD4FBD-D439-4028-B2FA-E6BADD9C5130Q30442031-5847CB7E-E68B-4083-8CE6-E75DB57725E8Q30452392-C0322ECD-96CC-4EA4-9870-0254D4A7CE4FQ31091721-3850F8C7-BEEF-4BCD-A918-67B9C6DDF3DAQ33729012-2391B859-797C-425D-9DC2-9AB689414F2FQ33756893-E9D32084-395C-41E3-B177-D38648A6EFFBQ33766147-27E7B9AD-28F9-42A9-B3AF-6CE9DA765B69Q33771987-BF64B7DB-3D58-4B63-9836-8EC4DA9C14D4Q33854087-2C71AA11-4815-4088-9788-E66916D13C08Q33933877-C02A4147-BB07-4B80-8BB1-A8C53FFB2A70Q34432578-0836EB5D-B2CE-4062-BE73-67D9239791D4Q34458640-C82B8E72-3276-4665-A923-BC39E8E9B303Q34471254-4B6E3B92-A6DD-4B40-90D9-02562DB76598Q34534903-528F2B39-A150-4AF2-B808-7B2EEA7C9508Q34542303-E3226B21-6C6E-4415-804C-81AA625AED69Q34984648-B07A89A8-90B6-44B6-BCE9-B76A6C8B7578Q35069476-E955B3BF-B000-4268-A19A-A46200B38C43Q35126288-78B11933-58CC-4475-BD4D-07A8D1D6E0EDQ35168712-4AF0B46E-A508-4696-8667-3BB9B29277E1Q35243704-BFB788B5-6909-44FA-8786-4DBA0400A8F0Q35654995-8EACDE30-5C2D-45B6-89A3-5568BB225400Q35673126-00AB9139-99F6-4B85-80E9-6D43876BA7F9Q35738974-86F5F97B-6BB6-4388-AD74-2CB75559EB8EQ35754509-629DD4E9-E4E2-4C46-9346-AD83017A500FQ35909333-318D053C-ABBE-4F11-A9FB-179642E28F83Q35938035-7B449DAA-BE07-4080-B6A3-FDE5F2C65575Q35968008-1DA53F18-23E0-49A7-A8C5-BD54E5B5B11CQ35987875-0FC24629-DA42-4C83-9FB4-14D7D62BEBACQ36124842-B68A039E-EE09-4DFF-A452-C528D691BB9BQ36148536-51F70E09-71CB-43C6-99E5-2A96267FE6BBQ36173389-51857503-65A0-44A3-B7C7-C73E7FE337E4Q36251798-10FCF30E-98D6-4F2C-8A92-32A1B0209594
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cognitive impairment in schizophrenia.
@en
type
label
Cognitive impairment in schizophrenia.
@en
prefLabel
Cognitive impairment in schizophrenia.
@en
P1476
Cognitive impairment in schizophrenia.
@en
P2093
Richard S E Keefe
P356
10.1007/978-3-642-25758-2_2
P577
2012-01-01T00:00:00Z